Shanghai-Israel Fund Lead $9M Round In Rapid Medical

Market Movers: BGI’s Upcoming $250 Million China IPO
July 17, 2017
Market Snapshot: C-Bridge Raises $400 Million For Second China Healthcare Fund
August 2, 2017

Shanghai-Israel Fund Lead $9M Round In Rapid Medical

 

Rapid Medical, an Israeli company focused on the development of neurovascular interventional devices, has completed a US$9 million series B financing to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products.

The round was led by Shanghai-Israel Investment Fund and Israeli investment firm BRM Group, with participation from Winnovation, a subsidiary of French Industrial group Bouygues, and U.S.-Israeli investment firm Gefen Capital.

 

The funding will support regulatory clearance as well as continuing to advance the European commercialization of Rapid Medical’s devices, including the Tigertriever Revascularization Device and the Comaneci Adjustable Remodeling Mesh.